New shot takes aim at stubborn high cholesterol
NCT ID NCT07421232
First seen Feb 24, 2026 · Last updated May 17, 2026 · Updated 17 times
Summary
This study tested a new injection called SYH2053 in 156 adults with high cholesterol or mixed high blood fats. Participants either received the new drug, a placebo (dummy shot), or an active comparator. The main goal was to see how much the drug lowered "bad" LDL cholesterol compared to the other groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliation: Peking University Third Hospital
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.